Calluna Pharma

Calluna Pharma is a biotechnology research company dedicated to developing innovative, first-in-class therapies to combat chronic inflammation and fibrosis. With a commitment to improving patient outcomes, Calluna Pharma focuses on therapeutic approaches that target the fundamental drivers of disease. The company's headquarters is located at Gaustadalléen 21, Oslo, 0349, NO.

Driven by the power of immunology, Calluna Pharma aims to push boundaries and challenge existing treatments. Calluna Pharma is committed to developing therapies that will make a significant difference in the lives of individuals facing serious diseases. The company's forward-thinking research and development efforts position it as a key player in the biotechnology sector, striving to enhance the quality of life for patients worldwide.

Calluna Pharma is rapidly advancing its clinical-stage programs, focusing on areas where current treatments fall short. The company's unwavering dedication to innovation and patient care underscores its mission to deliver transformative therapies. We invite the manager of Calluna Pharma to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.